Key Takeaways
- • Robert Iger (Disney CEO) and Henry Kravis (KKR co-founder) lead a group of five prominent investors purchasing a 3.3% minority stake in Thrive Capital for approximately $175 million, valuing the New York-based venture firm at roughly $5.3 billion.
- • The investor group includes billionaire Mukesh Ambani (Reliance Industries managing director) and Jorge Paulo Lemann, alongside Iger and Kravis, reflecting broad institutional and family office interest in Thrive Capital's venture portfolio.
- • Thrive Capital, founded by Josh Kushner, has become a focal point for institutional capital seeking exposure to artificial intelligence and high-growth technology investments, as evidenced by the firm's recent investor letter highlighting OpenAI-fueled growth.
- • The deal represents a secondary market transaction where Thrive Capital is selectively monetizing a minority stake while maintaining operational control, and signals the firm's confidence in its investment pipeline and valuation trajectory.
Summary
The investor group includes five prominent figures: Iger, Kravis, Mukesh Ambani (managing director of Reliance Industries), and Jorge Paulo Lemann, among others. This assemblage reflects strong demand from both corporate leadership and billionaire family offices for exposure to Thrive Capital's venture portfolio. The participation of Ambani, one of India's wealthiest businessmen, signals international institutional appetite for the firm's investment platform.
Thrive Capital has gained prominence in recent years through significant exposure to artificial intelligence and transformative technology investments. A recent investor letter from the firm emphasized growth fueled by investments including OpenAI, underscoring why institutional capital is actively seeking stakes in the venture manager. The firm is reportedly pursuing additional minority stake sales, suggesting a deliberate strategy to raise capital while retaining operational independence and founder control.
This transaction reflects a broader trend among elite venture capital firms to access permanent capital and institutional co-investment partnerships with established industry figures. For investors like Iger and Kravis, the stake provides direct exposure to Thrive Capital's deal flow and emerging technology trends without the operational burdens of managing a standalone venture fund.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.